1. Home
  2. KROS vs FSBC Comparison

KROS vs FSBC Comparison

Compare KROS & FSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KROS
  • FSBC
  • Stock Information
  • Founded
  • KROS 2015
  • FSBC 2002
  • Country
  • KROS United States
  • FSBC United States
  • Employees
  • KROS N/A
  • FSBC N/A
  • Industry
  • KROS Biotechnology: Pharmaceutical Preparations
  • FSBC Banks
  • Sector
  • KROS Health Care
  • FSBC Finance
  • Exchange
  • KROS Nasdaq
  • FSBC Nasdaq
  • Market Cap
  • KROS 460.6M
  • FSBC 650.2M
  • IPO Year
  • KROS 2020
  • FSBC 2021
  • Fundamental
  • Price
  • KROS $11.00
  • FSBC $29.89
  • Analyst Decision
  • KROS Buy
  • FSBC Buy
  • Analyst Count
  • KROS 11
  • FSBC 4
  • Target Price
  • KROS $45.33
  • FSBC $36.13
  • AVG Volume (30 Days)
  • KROS 2.1M
  • FSBC 44.9K
  • Earning Date
  • KROS 02-26-2025
  • FSBC 01-27-2025
  • Dividend Yield
  • KROS N/A
  • FSBC 2.69%
  • EPS Growth
  • KROS N/A
  • FSBC N/A
  • EPS
  • KROS N/A
  • FSBC 2.26
  • Revenue
  • KROS $651,000.00
  • FSBC $119,214,000.00
  • Revenue This Year
  • KROS $303.27
  • FSBC N/A
  • Revenue Next Year
  • KROS N/A
  • FSBC $15.51
  • P/E Ratio
  • KROS N/A
  • FSBC $13.38
  • Revenue Growth
  • KROS 8037.50
  • FSBC 4.22
  • 52 Week Low
  • KROS $9.78
  • FSBC $21.10
  • 52 Week High
  • KROS $73.00
  • FSBC $35.13
  • Technical
  • Relative Strength Index (RSI)
  • KROS 24.79
  • FSBC 41.97
  • Support Level
  • KROS $11.04
  • FSBC $28.95
  • Resistance Level
  • KROS $11.99
  • FSBC $31.50
  • Average True Range (ATR)
  • KROS 0.60
  • FSBC 0.96
  • MACD
  • KROS 1.20
  • FSBC 0.08
  • Stochastic Oscillator
  • KROS 43.99
  • FSBC 26.14

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

About FSBC Five Star Bancorp

Five Star Bancorp is a California state-chartered non-member bank. The Company provides a broad range of banking products and services to small and medium-sized businesses, professionals, and individuals. It offers loan products like commercial real estate loans, commercial loans, commercial land and construction loans, and farmland loans and offers deposit products like checking accounts, savings accounts, money market accounts, and term certificate accounts.

Share on Social Networks: